Specialists at the Scientific Research Institute “AGAT”, located in the town of Zhukovsky, in the Moscow Region, applied a small device to the inside of the palm and identified the required value with a touch of a button. The small device, the size of a telephone receiver, is a two-channel spectrophotometer, which determines the absorption or irradiation of light of a definite wavelength. It operates as follows.
A fibreoptic block is tightly pressed to the skin, usually on the inside of the palm because the skin is thinner here and has less pigmentation. The flashbulb light travels along the optical fiber onto the body surface, where it is partly reflected and partly absorbed by the top layers of the skin and also by the blood. Bilirubin absorbs and reflects specific wavelengths of light which can then be measured.
This reflected, or more precisely, diffusely reflected (i.e. dispersed by tissue) signal travels via the other optical fibre into photoelectric receptors. It then passes through two channels with a light filter set at 460 and 550 nanometer wavelengths. Two channels allow comparison of reflected radiation at two wavelengths. The device rejects the background radiation to leave behind the bilirubin signal.
The device can determine the bilirubin concentration in the blood from zero to 400 micromoles per litre, where 400 is the highest value possible in cases of extreme jaundice. The device including batteries weighs 470 grams and takes just over a minute to measure one reading and prepare for the next. This analyzer is ideal to check large groups of the population for jaundice and as no injections are involved, there is no opportunity to transmit infections between patients.
Nadezda Markina | alfa
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences